Evidence map›Paper›PMID 28792506›Full record

ArticlePloS one2017

Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach.

Lionel Buré, Louis-Martin Boucher, Miriam Blumenkrantz, Stefan Schob, Pierre Lafaye de Micheaux, Caroline Reinhold, Benoit Gallix

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Lionel BuréDepartment of Radiology, McGill University Health Center, Montreal General Hospital, Montreal, Qc, Canada.ORCID http://orcid.org/0000-0002-1292-9875
Louis-Martin BoucherDepartment of Radiology, McGill University Health Center, Montreal General Hospital, Montreal, Qc, Canada.
Miriam BlumenkrantzDepartment of Adult and Pediatric Pathology, McGill University Health Center, Royal Victoria Hospital, Montreal, Qc, Canada.
Stefan SchobDepartment of Neuroradiology, Leipzig University Hospital, Leipzig, Germany.
Pierre Lafaye de MicheauxSchool of Mathematics and Statistics, University of New South Wales, Sydney, Australia.
Caroline ReinholdDepartment of Radiology, McGill University Health Center, Montreal General Hospital, Montreal, Qc, Canada.
Benoit GallixDepartment of Radiology, McGill University Health Center, Montreal General Hospital, Montreal, Qc, Canada.
Montreal General Hospital · CARoyal Victoria Regional Health Centre · CAUniversity Hospital Leipzig · DEUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphadenopathy continues to be a common problem to radiologists and treating physicians because of the difficulty in confidently categorizing a node as being benign or malignant using standard diagnostic techniques. The goal of our research was to assess whether magnetic resonance (MR) spectroscopy contains the necessary information to allow differentiation of benign from malignant lymph nodes in an in-vitro approach using a modern pattern recognition method. Tissue samples from a tissue bank were analyzed on a nuclear magnetic resonance (NMR) spectrometer. A total of 69 samples were studied. The samples included a wide variety of malignant and benign etiologies. Using 45 samples, we initially created a model which was able to predict if a certain spectrum originates from benign or malignant lymph nodes using a pattern-recognition technique which takes into account the entire magnetic spectrum rather than single peaks alone. The remaining 24 samples were blindly loaded in the model to assess its performance. We obtained an excellent accuracy in differentiating benign and malignant lymphadenopathy using the model. It correctly differentiated as malignant or benign, in a blinded fashion, all of the malignant samples (13 of 13) and 10 out of the 11 benign samples. We thus showed that magnetic spectroscopy is able to differentiate benign from malignant causes of lymphadenopathy. Additional experiments were performed to verify that the differentiating abilities of our model were not due to differential tissue decay in between benign and malignant tissues. If future experiments demonstrate that a similar approach could be executed with standard MR imaging, this technique could be useful as a problem-solving tool when assessing lymphadenopathy in general. Alternatively, our in-vitro technique could also be useful to pathologists faced with indeterminate pathologies of the lymph nodes after validating our results with a larger sample size.

Indexed as

Proton Magnetic Resonance SpectroscopyDiagnosis, Computer-AssistedDiagnosis, DifferentialDiscriminant AnalysisHumansLymphadenopathyLymphatic MetastasisLymph NodesModels, TheoreticalSingle-Blind MethodSoftware

Identifiers

PMID28792506
PMCPMC5549694
OpenAlexW2743552787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.